Position in PFE
as of Jun 30, 2026
· filed Aug 17, 2026
Position Value
$67,458,829
-$4,381,857 QoQ
Shares Held
2,945,297
+15.1% QoQ
Ownership
0.052%
of shares outstanding
% of Portfolio
0.12%
of 13F equity value
Holder Rank
#131
of 2,821 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority
Sole 27%
Shared 6%
None 67%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Corient Private Wealth LLC holds $2,818,388,817 across 16 Drug Manufacturers - General names. PFE ranks #8 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
1,206,575 | $764,096,470 | |
| 2 | JNJ |
Johnson & Johnson
|
6,060,922 | $672,880,917 | |
| 3 | ABBV |
AbbVie Inc.
|
19,562,230 | $557,310,914 | |
| 4 | MRK |
Merck & Co., Inc.
|
2,683,612 | $322,525,314 | |
| 5 | AMGN |
Amgen Inc
|
1,041,051 | $187,400,837 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
2,478,397 | $73,717,881 | |
| 7 | NVS |
Novartis AG
|
447,726 | $70,167,618 | |
| 8 | PFE |
Pfizer Inc
This page
|
2,945,297 | $67,458,829 |
All Filings in PFE
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $67,310,751 | 2,795,297 | Shares | Sole | 2026-08-17 | |
| 2026-06-30 | $148,078 | 150,000 | Principal | Sole | 2026-08-17 | |
| 2026-03-31 | $71,840,686 | 2,558,429 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $70,460,102 | 2,829,723 | Shares | Sole | 2026-03-09 | |
| 2025-09-30 | $74,259,801 | 2,914,435 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $49,802,872 | 2,054,574 | Shares | Other | 2025-09-26 | |
| 2025-03-31 | $56,618,756 | 2,234,363 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $69,978,365 | 2,637,707 | Shares | Other | 2025-02-10 | |
| 2024-09-30 | $90,368,650 | 3,122,621 | Shares | Other | 2024-11-12 | |
| 2024-06-30 | $96,329,767 | 3,442,808 | Shares | Other | 2024-08-13 | |
| 2024-03-31 | $96,079,156 | 3,462,312 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $99,119,190 | 3,442,834 | Shares | Other | 2024-02-09 | |
| 2023-09-30 | $104,941,221 | 3,163,739 | Shares | Other | 2023-11-03 | |
| 2023-06-30 | $115,109,357 | 3,138,205 | Shares | Other | 2023-08-10 | |
| 2023-03-31 | $109,595,939 | 2,686,175 | Shares | Other | 2023-05-15 | |
| 2022-12-31 | $118,294,097 | 2,308,628 | Shares | Other | 2023-02-15 | |
| No filing history on record for this holder in this stock. | ||||||